Concepedia

Trisha A. Denny

TA

5

Publications

249

Citations

5

H-Index

2005

Active since

Affiliations

University of British Columbia(Current)

Trisha A. Denny is an author at University of British Columbia specializing in medicine, apoptosis, and cell signaling.

Top concepts

Publications per year

2005–2019

5

Publications

5

ENMD-2076 Is an Orally Active Kinase Inhibitor with Antiangiogenic and Antiproliferative Mechanisms of Action

Graham C. Fletcher, Richard D. Brokx, Trisha A. Denny et al. · Molecular Cancer Therapeutics · 2010 · 128 citations

Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial

Zachary Veitch, David W. Cescon, Trisha A. Denny et al. · British Journal of Cancer · 2019 · 66 citations · Full text

Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors

Sampath‐Kumar Anandan, John S. Ward, Richard D. Brokx et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 30 citations · Full text

, , +7

Cytokine-mediated FOXO3a phosphorylation suppresses FasL expression in hemopoietic cell lines: Investigations of the role of Fas in apoptosis due to cytokine starvation

Hayedeh Behzad, Sarwat Jamil, Trisha A. Denny et al. · Cytokine · 2007 · 14 citations

, , +15

Phosphorylation of Bad is not essential for PKB-mediated survival signaling in hemopoietic cells

S. W. Wang, Trisha A. Denny, Urs P. Steinbrecher et al. · APOPTOSIS · 2005 · 11 citations

, , +13

Rows per page

1–5 of 5